Similar articles for PMID: 32014968

Year	Number of Results
2001	1
2004	1
2007	1
2008	4
2009	3
2010	5
2011	2
2012	5
2013	9
2014	8
2015	18
2016	13
2017	17
2018	6
2019	16
2020	6
2021	4
2022	6
2023	3
2024	0

1

Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery.

Ohsawa M, Hamai Y, Emi M, Takaoki F, Ibuki Y, Tomoaki K, Yoshikawa T, Okada M. Ohsawa M, et al. Anticancer Res. 2020 Feb;40(2):1153-1160. doi: 10.21873/anticanres.14057. Anticancer Res. 2020. PMID: 32014968

2

Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.

Izumi D, Yoshida N, Watanabe M, Shiraishi S, Ishimoto T, Kosumi K, Tokunaga R, Taki K, Higashi T, Harada K, Miyata T, Ida S, Imamura Y, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yamashita Y, Baba H. Izumi D, et al. J Gastroenterol. 2016 Aug;51(8):788-95. doi: 10.1007/s00535-015-1150-4. Epub 2015 Dec 15. J Gastroenterol. 2016. PMID: 26671045

3

Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).

Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y. Miyata H, et al. Ann Surg Oncol. 2014 Feb;21(2):575-82. doi: 10.1245/s10434-013-3343-5. Epub 2013 Nov 8. Ann Surg Oncol. 2014. PMID: 24201746

4

Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.

Hamai Y, Hihara J, Emi M, Furukawa T, Yamakita I, Kurokawa T, Okada M. Hamai Y, et al. Ann Thorac Surg. 2016 Oct;102(4):1132-9. doi: 10.1016/j.athoracsur.2016.04.011. Epub 2016 Jun 17. Ann Thorac Surg. 2016. PMID: 27319990

5

Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.

Nakao R, Konishi E, Fujiwara H, Otsuji E, Yokota I, Urata Y, Yanagisawa A. Nakao R, et al. Int J Surg Pathol. 2019 Oct;27(7):713-721. doi: 10.1177/1066896919855760. Epub 2019 Jun 17. Int J Surg Pathol. 2019. PMID: 31203677

6

FDG PET using SUV_max for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.

Huang YC, Lu HI, Huang SC, Hsu CC, Chiu NT, Wang YM, Chiu YC, Li SH. Huang YC, et al. BMC Med Imaging. 2017 Jan 5;17(1):1. doi: 10.1186/s12880-016-0171-7. BMC Med Imaging. 2017. PMID: 28056868 Free PMC article.

7

Combining the radiomic features and traditional parameters of ¹⁸F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.

Chen YH, Lue KH, Chu SC, Chang BS, Wang LY, Liu DW, Liu SH, Chao YK, Chan SC. Chen YH, et al. Ann Nucl Med. 2019 Sep;33(9):657-670. doi: 10.1007/s12149-019-01380-7. Epub 2019 Jun 19. Ann Nucl Med. 2019. PMID: 31218571

8

Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma.

Huang TC, Lin CC, Wu YC, Chia-Hsien Cheng J, Lee JM, Wang HP, Huang PM, Hsu FM, Yeh KH, Cheng AL, Tzen KY, Hsu CH. Huang TC, et al. J Formos Med Assoc. 2019 Jun;118(6):1024-1030. doi: 10.1016/j.jfma.2018.11.003. Epub 2018 Nov 28. J Formos Med Assoc. 2019. PMID: 30502100 Free article. Clinical Trial.

9

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy.

Molena D, Sun HH, Badr AS, Mungo B, Sarkaria IS, Adusumilli PS, Bains MS, Rusch VW, Ilson DH, Rizk NP. Molena D, et al. Dis Esophagus. 2014 May-Jun;27(4):355-9. doi: 10.1111/dote.12126. Epub 2013 Aug 29. Dis Esophagus. 2014. PMID: 24033404

10

Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.

Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C. Piessen G, et al. Ann Surg. 2013 Jul;258(1):66-76. doi: 10.1097/SLA.0b013e31828676c4. Ann Surg. 2013. PMID: 23470576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year